1st Quarter - Report

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$760,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2016 $760,000 Replaced
1st Quarter - Amendment Apr 28, 2016 $760,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
GREGG HAIFLEY —
RACHEL MARCUS New —
CAROLINE POWERS —
RICHARD WOODRUFF —

Contacted: Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; White House Office; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.

Contacted: Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); White House Office; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Labor, Dept of (DOL); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Bills named: S. 1014 (114th), H.R. 3119 (114th), H.R. 1608 (114th), H.R. 2739 (114th), S. 705 (114th), S. 370 (114th), H.R. 2846 (114th), H.R. 716 (114th), H.R. 2191 (114th), H.R. 644 (114th), S. 1566 (114th), S. 1170 (114th), S. 540 (114th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.__, the FY17 Agriculture Appropriations legislation and issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation.

Contacted: HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); SENATE; White House Office; U.S. Trade Representative (USTR); State, Dept of (DOS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC)

Bills named: H.Con.Res. 25 (114th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in H.R.__, FY17 Agriculture Appropriations legislation.

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); Labor, Dept of (DOL); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Natl Institutes of Health (NIH); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1129 (114th), H.R. 478 (114th), H.R. 1749 (114th), S. 430 (114th), S. 450 (114th), H.R. 3042 (114th)

Medicare/Medicaid MMM

Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act.

Contacted: White House Office; SENATE; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS)

Bills named: H.R. 1190 (114th), H.R. 1220 (114th), S. 624 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.